CD4 and COVID-19: (10) demonstrated that SARS-CoV-2-specific CD4+ T cell responses were found in 100% of patients convalescing from COVID-19, with the majority of the CD4+ T cell reactivity directed to SARS-CoV-2 spike, M, and N proteins.